About DreaMed
DreaMed is a company based in Petah Tikva (Israel) founded in 2014 by Eran Atlas. DreaMed has raised $8.3 million across 5 funding rounds from investors including Medtronic, eHealth Ventures and Norma Investment. DreaMed offers products and services including endo.digital, Uploader, and Mobile App. DreaMed operates in a competitive market with competitors including Fitterfly, Glytec Systems, Vitadio, Steady Health and Hillo, among others.
- Headquarter Petah Tikva, Israel
- Founders Eran Atlas
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.3 M (USD)
in 5 rounds
-
Latest Funding Round
$3 M (USD), Series A
Aug 19, 2024
-
Investors
Medtronic
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DreaMed
DreaMed offers a comprehensive portfolio of products and services, including endo.digital, Uploader, and Mobile App.
Cloud-based tool for diabetes decision support and data management.
Platform to acquire and upload diabetes device data securely.
App for tracking and managing diabetes events and treatments.
People of DreaMed
Unlock access to complete
Unlock access to complete
Funding Insights of DreaMed
DreaMed has successfully raised a total of $8.3M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DreaMed
DreaMed has secured backing from 5 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Medtronic, eHealth Ventures and Norma Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage digital health ventures are funded and supported.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
A charitable trust focused on healthcare and research funding.
|
Locked | Locked | Locked |
Investor details for DreaMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DreaMed
Investment portfolio details for DreaMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DreaMed
Detailed financials for DreaMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dreamed Comparisons
Peer comparison for DreaMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DreaMed
DreaMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fitterfly, Glytec Systems, Vitadio, Steady Health and Hillo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A mobile app is offered for managing multiple chronic diseases.
|
|
| Locked | Locked | Locked |
Offers cloud-based SaaS for diabetes management and insulin dosing in hospitals.
|
|
| Locked | Locked | Locked |
Online platform for diabetic patients' management and information is provided.
|
|
| Locked | Locked | Locked |
Diabetes management app is provided to patients by Steady Health.
|
|
| Locked | Locked | Locked |
Provider of clinical decision tool for healthcare professionals
|
Detailed competitors of DreaMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dreamed
Complete news archive for DreaMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DreaMed
DreaMed was founded in 2014 and raised its 1st funding round 1 year after it was founded.
DreaMed is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.
Eran Atlas is the current CEO of DreaMed. They have also founded this company.
DreaMed is a funded company, having raised a total of $8.3M across 5 funding rounds to date.
DreaMed was founded in 2014 in Petah Tikva, Israel, focusing on health technology for diabetes care. An AI-driven clinical decision support system is developed to assist providers. The initial product, Endo.digital, operates as a cloud-based SaaS platform, enabling end-to-end diabetes pathways. Deployment occurs across various care settings, including remote and in-person treatments for patients.
DreaMed's top competitors include Fitterfly, Vitadio and Steady Health.
DreaMed offers endo.digital, Uploader, and Mobile App.
DreaMed has 5 investors. Key investors include Medtronic, eHealth Ventures, Norma Investment, Roman Abramovich, and Helmsley Charitable Trust.